Open Label Extension Study of Epratuzumab in Subjects With Systemic Lupus Erythematosus
Public ClinicalTrials.gov record NCT01408576. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Open-label, Extension Study to Assess the Safety and Tolerability of Epratuzumab Treatment in Systemic Lupus Erythematosus Subjects
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of the study is assess the safety and tolerability of long-term epratuzumab treatment in subjects with Systemic Lupus Erythematosus (SLE)
Study identification
- NCT ID
- NCT01408576
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,250 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2011 (Type not available)
- Primary completion
- Feb 2016 (Actual)
- Completion
- Feb 2016 (Actual)
- Last update posted
- Oct 3, 2018
2011 – 2016
United States locations
- U.S. sites
- 78
- U.S. states
- 25
- U.S. cities
- 66
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 539 | Birmingham | Alabama | — | — |
| 557 | Little Rock | Arkansas | — | — |
| 515 | Hemet | California | — | — |
| 544 | Huntington Beach | California | — | — |
| 550 | La Jolla | California | — | — |
| 031 | Los Angeles | California | — | — |
| 051 | Los Angeles | California | — | — |
| 089 | Los Angeles | California | — | — |
| 531 | San Leandro | California | — | — |
| 594 | Thousand Oaks | California | — | — |
| 558 | Torrance | California | — | — |
| 048 | Aurora | Colorado | — | — |
| 037 | Colorado Springs | Colorado | — | — |
| 532 | Denver | Colorado | — | — |
| 511 | Bridgeport | Connecticut | — | — |
| 039 | Farmington | Connecticut | — | — |
| 042 | Aventura | Florida | — | — |
| 514 | Brandon | Florida | — | — |
| 090 | Clearwater | Florida | — | — |
| 092 | DeBary | Florida | — | — |
| 533 | Fort Lauderdale | Florida | — | — |
| 064 | Jupiter | Florida | — | — |
| 070 | Ormond Beach | Florida | — | — |
| 084 | Palm Harbor | Florida | — | — |
| 518 | Plantation | Florida | — | — |
| 585 | Port Orange | Florida | — | — |
| 050 | Tampa | Florida | — | — |
| 538 | Tampa | Florida | — | — |
| 087 | Vero Beach | Florida | — | — |
| 537 | Atlanta | Georgia | — | — |
| 044 | Duluth | Georgia | — | — |
| 590 | Idaho Falls | Idaho | — | — |
| 052 | Chicago | Illinois | — | — |
| 096 | Indianapolis | Indiana | — | — |
| 060 | Shreveport | Louisiana | — | — |
| 513 | Lansing | Michigan | — | — |
| 599 | Lansing | Michigan | — | — |
| 047 | Saint Clair Shores | Michigan | — | — |
| 575 | Florissant | Missouri | — | — |
| 549 | St Louis | Missouri | — | — |
| 596 | Nashua | New Hampshire | — | — |
| 568 | Freehold | New Jersey | — | — |
| 593 | Trenton | New Jersey | — | — |
| 067 | Las Cruces | New Mexico | — | — |
| 551 | Brooklyn | New York | — | — |
| 553 | Great Neck | New York | — | — |
| 545 | Manhasset | New York | — | — |
| 053 | New York | New York | — | — |
| 577 | Roslyn | New York | — | — |
| 077 | Charlotte | North Carolina | — | — |
| 559 | Charlotte | North Carolina | — | — |
| 058 | Durham | North Carolina | — | — |
| 075 | Wilmington | North Carolina | — | — |
| 061 | Columbus | Ohio | — | — |
| 071 | Middleburg Heights | Ohio | — | — |
| 041 | Oklahoma City | Oklahoma | — | — |
| 076 | Oklahoma City | Oklahoma | — | — |
| 097 | Oklahoma City | Oklahoma | — | — |
| 547 | Tulsa | Oklahoma | — | — |
| 032 | Duncansville | Pennsylvania | — | — |
| 093 | Philadelphia | Pennsylvania | — | — |
| 073 | Pittsburgh | Pennsylvania | — | — |
| 094 | Pittsburgh | Pennsylvania | — | — |
| 535 | Charleston | South Carolina | — | — |
| 598 | Myrtle Beach | South Carolina | — | — |
| 571 | Jackson | Tennessee | — | — |
| 057 | Memphis | Tennessee | — | — |
| 574 | Amarillo | Texas | — | — |
| 078 | Austin | Texas | — | — |
| 098 | Austin | Texas | — | — |
| 570 | Austin | Texas | — | — |
| 079 | Dallas | Texas | — | — |
| 541 | Houston | Texas | — | — |
| 563 | Houston | Texas | — | — |
| 036 | Mesquite | Texas | — | — |
| 066 | San Antonio | Texas | — | — |
| 562 | San Antonio | Texas | — | — |
| 534 | Seattle | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 150 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01408576, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 3, 2018 · Synced Sep 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01408576 live on ClinicalTrials.gov.